Article
Synthesis and ITC characterization of novel nanoparticles constituted by poly(gamma-benzyl L-glutamate)-beta-cyclodextrin.
UMR CNRS 8612, Laboratoire de Pharmacotechnie et Biopharmacie, Faculté de Pharmacie, Université Paris-Sud, 5 rue J. B. Clément, 92290 Châtenay-Malabry, France.
Journal of Molecular Recognition (impact factor:
3.31).
21(3):169-78.
DOI:10.1002/jmr.882
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Pegylation of poly(γ-benzyl-L-glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats.
[show abstract] [hide abstract]
ABSTRACT: Poly(γ-benzyl-L-glutamate) (PBLG) derivatives are synthetic polypeptides for preparing nanoparticles with well controlled surface properties. The aim of this paper was to investigate the biodistribution of pegylated PBLG in rats. For this purpose, nanoparticles were prepared by a nanoprecipitation method using mixtures of different PBLG derivates, including a pegylated derivate to avoid mononuclear phagocyte system uptake. The morphology, size distribution, and surface charge of the nanoparticles were investigated as a function of the amount of polymer employed for the preparation. Moderately polydispersed nanoparticles (polydispersity index less than 0.2) were obtained. Their size increased with polymer concentration. The zeta potential values were negative whatever the formulations. The availability of polyethylene glycol chains on the nanoparticles' surface was confirmed by measuring the decrease in bovine serum albumin adsorption. For in vivo distribution studies, pegylated and nonpegylated nanoparticles were prepared with polymer mixtures containing PBLG-fluorescein isothiocyanate and imaged by fluorescence microscopy to measure their accumulation in liver and spleen tissues of rats after intravenous administration. Injection of stealth formulations resulted in negligible fluorescence in liver and spleen compared with nonpegylated formulations, which suggests that these nanoparticles are promising candidates as a stealth-type long-circulating drug carrier system and could be useful for active targeting of drugs while reducing systemic side effects.International Journal of Nanomedicine 01/2010; 5:1103-11. · 3.13 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
dynamic laser light scattering
Imparting desired technological characteristics
isothermal titration microcalorimetry
large amounts
mixtures
modified nanoprecipitation method
Nanoparticles
necessary
novel PBLG-derivative
original polymers
polymeric nanoparticles
surfactant
suspension medium
transmission electron microscopy